These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9550473)

  • 21. A fibronectin fragment induces type II collagen degradation by collagenase through an interleukin-1-mediated pathway.
    Yasuda T; Poole AR
    Arthritis Rheum; 2002 Jan; 46(1):138-48. PubMed ID: 11817586
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
    Abdollahi-Roodsaz S; Joosten LA; Helsen MM; Walgreen B; van Lent PL; van den Bersselaar LA; Koenders MI; van den Berg WB
    Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice.
    Chambers MG; Cox L; Chong L; Suri N; Cover P; Bayliss MT; Mason RM
    Arthritis Rheum; 2001 Jun; 44(6):1455-65. PubMed ID: 11407708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data.
    Bendele A; McAbee T; Sennello G; Frazier J; Chlipala E; McCabe D
    Arthritis Rheum; 1999 Mar; 42(3):498-506. PubMed ID: 10088773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritis.
    Gabay C; Marinova-Mutafchieva L; Williams RO; Gigley JP; Butler DM; Feldmann M; Arend WP
    Arthritis Rheum; 2001 Feb; 44(2):451-62. PubMed ID: 11229477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The protective effect of interleukin-1 receptor antagonist on postischemic reperfused myocardium and its possible mechanism].
    Li YJ; Ding WH; Gao W; Huo Y; Hong T; Zhu RY; Ma DL
    Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):548-53. PubMed ID: 15144587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crucial role of macrophages in matrix metalloproteinase-mediated cartilage destruction during experimental osteoarthritis: involvement of matrix metalloproteinase 3.
    Blom AB; van Lent PL; Libregts S; Holthuysen AE; van der Kraan PM; van Rooijen N; van den Berg WB
    Arthritis Rheum; 2007 Jan; 56(1):147-57. PubMed ID: 17195217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of metalloproteinase activity, cartilage matrix degradation and inhibition of endochondral mineralization in vitro by E. coli lipopolysaccharide is mediated by interleukin 1 alpha.
    Scheller M; Zimmermann B; Bernimoulin JP; Scholz P
    Cytokine; 1995 May; 7(4):331-7. PubMed ID: 8589263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electrotransfer of human IL-1Ra into skeletal muscles reduces the incidence of murine collagen-induced arthritis.
    Jeong JG; Kim JM; Ho SH; Hahn W; Yu SS; Kim S
    J Gene Med; 2004 Oct; 6(10):1125-33. PubMed ID: 15452879
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction.
    Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G
    Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Local IL-13 gene transfer prior to immune-complex arthritis inhibits chondrocyte death and matrix-metalloproteinase-mediated cartilage matrix degradation despite enhanced joint inflammation.
    Nabbe KC; van Lent PL; Holthuysen AE; Sloëtjes AW; Koch AE; Radstake TR; van den Berg WB
    Arthritis Res Ther; 2005; 7(2):R392-401. PubMed ID: 15743487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation.
    Joosten LA; Helsen MM; Saxne T; van De Loo FA; Heinegard D; van Den Berg WB
    J Immunol; 1999 Nov; 163(9):5049-55. PubMed ID: 10528210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection against collagen-induced arthritis by intramuscular gene therapy with an expression plasmid for the interleukin-1 receptor antagonist.
    Kim JM; Jeong JG; Ho SH; Hahn W; Park EJ; Kim S; Yu SS; Lee YW; Kim S
    Gene Ther; 2003 Sep; 10(18):1543-50. PubMed ID: 12907945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Local overexpression of adeno-viral IL-4 protects cartilage from metallo proteinase-induced destruction during immune complex-mediated arthritis by preventing activation of pro-MMPs.
    van Lent PL; Holthuysen AE; Slöetjes A; Lubberts E; van den Berg WB
    Osteoarthritis Cartilage; 2002 Mar; 10(3):234-43. PubMed ID: 11869085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy.
    Nixon AJ; Haupt JL; Frisbie DD; Morisset SS; McIlwraith CW; Robbins PD; Evans CH; Ghivizzani S
    Gene Ther; 2005 Jan; 12(2):177-86. PubMed ID: 15578043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyaluronan enhances cartilage repair through low grade tissue remodeling involving cytokines and matrix metalloproteinases.
    Homandberg GA; Ummadi V; Kang H
    Inflamm Res; 2004 Oct; 53(10):534-43. PubMed ID: 15597148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4.
    Lubberts E; Joosten LA; van de Loo FA; van den Gersselaar LA; van den Berg WB
    Arthritis Rheum; 2000 Jun; 43(6):1300-6. PubMed ID: 10857788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.
    Koenders MI; Devesa I; Marijnissen RJ; Abdollahi-Roodsaz S; Boots AM; Walgreen B; di Padova FE; Nicklin MJ; Joosten LA; van den Berg WB
    Arthritis Rheum; 2008 Nov; 58(11):3461-70. PubMed ID: 18975337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
    Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of interleukin I receptor antigonist gene therapy on arthritis induced by type II collagen in mice].
    Yang G; Di C; Jiang M; Li F; Zhang Y; Yuan L; Song Q; Ma D
    Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):990-4. PubMed ID: 12181096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.